DSGN Competitors & Alternatives
Compare Design Therapeutics Inc with similar stocks in the same industry
Biotechnology
DSGN
Main Stock$13.64
Tradestie Score
57
Market Cap
$386.68M
Analyst Upside
+54.0%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
URGN
UroGen Pharma Ltd. Ordinary Shares
|
$34.71
|
$824.20M | - | 59 | Compare |
|
IVA
Inventiva S.A. American Depository Shares
|
$3.64
|
$821.84M | - | 52 | Compare |
|
MBX
MBX Biosciences, Inc. Common Stock
|
$44.73
|
$800.41M | - | 56 | Compare |
|
IOVA
Iovance Biotherapeutics, Inc. Common Stock
|
$4.27
|
$799.70M | - | 56 | Compare |
|
KURA
Kura Oncology, Inc.
|
$10.45
|
$798.53M | - | 57 | Compare |
|
VIR
Vir Biotechnology, Inc. Common Stock
|
$9.99
|
$791.82M | - | 63 | Compare |
|
EVMN
EVMN
|
$23.21
|
$769.35M | - | 65 | Compare |
|
OLMA
Olema Pharmaceuticals, Inc. Common Stock
|
$10.61
|
$757.72M | - | 55 | Compare |
|
AVBP
ArriVent BioPharma, Inc. Common Stock
|
$34.27
|
$748.90M | - | 70 | Compare |
|
TBPH
Theravance Biopharma, Inc.
|
$16.84
|
$726.21M | 7.4 | 61 | Compare |
More DSGN Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry